Dynavax Technologies Corp (NAS:DVAX)
$ 13 -0.03 (-0.23%) Market Cap: 1.71 Bil Enterprise Value: 1.17 Bil PE Ratio: 100.23 PB Ratio: 2.51 GF Score: 70/100

Q1 2019 Dynavax Technologies Corp Earnings Call Transcript

May 08, 2019 / 08:30PM GMT
Release Date Price: $6.53 (+0.31%)
Operator

Good day, ladies and gentlemen and welcome to the Dynavax Technologies First Quarter 2019 Conference Call. As a reminder, this conference call is being recorded.

I would now like to introduce your host for today's conference, Miss Heather Rowe, Vice President of Investor Relations and Corporate Communications. You may begin.

Heather Rowe
Dynavax Technologies Corporation - VP of IR & Corporate Communications

Thank you, operator. Good afternoon. Welcome to the Dynavax First Quarter 2019 Financial Results and Corporate Update Conference Call. With me today are Eddie Gray, Chief Executive Officer; Michael Ostrach, Chief Financial Officer; Rob Janssen, Chief Medical Officer; and Ryan Spencer, Vice President of Corporate Strategy and Commercial Operations.

Before we begin, I advise you that we will be making forward-looking statements today, including statements regarding clinical and financial information, expectations regarding HEPLISAV-B, including the amount and timing of sales, revenue and profitability; rates of adoption and reorder

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot